The GO analyses showed that the oxidation-reduction, immune system process, metabolic process and P450 pathway were the top biological processes altered during NAFLD/NASH progression, which were attenuated by bicyclol treatment. Here, CYP2B6 is linked to metabolic dysfunction-associated steatohepatitis.